Suzuki T - Search Results

1

Accelerating response to antidepressant treatment in depression: a review and clinical suggestions.

Nakajima S, Suzuki T, Watanabe K, Kashima H, Uchida H. Nakajima S, et al. Among authors: suzuki t. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):259-64. doi: 10.1016/j.pnpbp.2009.12.001. Epub 2009 Dec 5. Prog Neuropsychopharmacol Biol Psychiatry. 2010. PMID: 19969039 Review.

2

The first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania.

Kanba S, Yagi G, Kamijima K, Suzuki T, Tajima O, Otaki J, Arata E, Koshikawa H, Nibuya M, Kinoshita N, et al. Kanba S, et al. Among authors: suzuki t. Prog Neuropsychopharmacol Biol Psychiatry. 1994 Jul;18(4):707-15. doi: 10.1016/0278-5846(94)90078-7. Prog Neuropsychopharmacol Biol Psychiatry. 1994. PMID: 7938561 Clinical Trial.

3

Recurrent episodes of perceptual alteration in patients treated with antipsychotic agents.

Uchida H, Suzuki T, Tanaka KF, Watanabe K, Yagi G, Kashima H. Uchida H, et al. Among authors: suzuki t. J Clin Psychopharmacol. 2003 Oct;23(5):496-9. doi: 10.1097/01.jcp.0000088910.24613.44. J Clin Psychopharmacol. 2003. PMID: 14520127

4

Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia.

Suzuki T, Uchida H, Tanaka KF, Tomita M, Tsunoda K, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H. Suzuki T, et al. Int Clin Psychopharmacol. 2003 Nov;18(6):323-9. doi: 10.1097/00004850-200311000-00003. Int Clin Psychopharmacol. 2003. PMID: 14571152

5

Antipsychotic-induced paroxysmal perceptual alteration.

Uchida H, Suzuki T, Watanabe K, Yagi G, Kashima H. Uchida H, et al. Among authors: suzuki t. Am J Psychiatry. 2003 Dec;160(12):2243-4. doi: 10.1176/appi.ajp.160.12.2243-a. Am J Psychiatry. 2003. PMID: 14638603 No abstract available.

6

Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia.

Suzuki T, Uchida H, Tanaka KF, Nomura K, Takano H, Tanabe A, Watanabe K, Yagi G, Kashima H. Suzuki T, et al. Int J Neuropsychopharmacol. 2004 Jun;7(2):133-42. doi: 10.1017/S1461145703004012. Epub 2004 Jan 23. Int J Neuropsychopharmacol. 2004. PMID: 14741059 Free article. Clinical Trial.

7

A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.

Suzuki T, Uchida H, Watanabe K, Yagi G, Kashima H. Suzuki T, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):361-9. doi: 10.1016/j.pnpbp.2003.11.006. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 14751434 Clinical Trial.

8

Simplifying psychotropic medication regimen into a single night dosage and reducing the dose for patients with chronic schizophrenia.

Suzuki T, Uchida H, Takeuchi H, Nomura K, Tanabe A, Watanabe K, Yagi G, Kashima H. Suzuki T, et al. Psychopharmacology (Berl). 2005 Sep;181(3):566-75. doi: 10.1007/s00213-005-0018-3. Epub 2005 Oct 12. Psychopharmacology (Berl). 2005. PMID: 15991004 Clinical Trial.

9

[Is it valid to concurrently use multiple antipsychotics for patients with schizophrenia?].

Suzuki T, Watanabe K, Yagi G, Kashima H. Suzuki T, et al. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005 Aug;25(4):159-68. Nihon Shinkei Seishin Yakurigaku Zasshi. 2005. PMID: 16190364 Review. Japanese.

10

Two case reports of successful prevention of overdosing in borderline patients.

Uchida H, Watanabe K, Suzuki T, Goto A, Kashima H. Uchida H, et al. Among authors: suzuki t. Psychiatry. 2005;68(2):179-82. doi: 10.1521/psyc.2005.68.2.179. Psychiatry. 2005. PMID: 16247861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,475 results

Search Page

Filters